Literature DB >> 20683013

Cell-free circulating DNA: Diagnostic value in patients with renal cell cancer.

Stefan Hauser1, Tobias Zahalka, Jörg Ellinger, Guido Fechner, Lukas C Heukamp, Alexander VON Ruecker, Stefan C Müller, Patrick J Bastian.   

Abstract

OBJECTIVES: To analyse the diagnostic and prognostic value of cell-free DNA in patients with renal cell carcinoma (RCC). PATIENTS AND METHODS: Cell-free DNA was measured in 35 patients with RCC and 54 healthy individuals using quantitative real-time PCR. ACTB-106 detects fragmented cell-free DNA due to apoptosis and ACTB-384 detects long DNA fragments by necrosis. DNA-Integrity (ACTB-384/ACTB-106 ratio) served as measure of DNA fragmentation.
RESULTS: Levels of both DNA fragments were increased in RCC patients compared to healthy individuals (ACTB-384: 1.77 vs. 0.61ng/ml, p=0.0003; ACTB-106: 1.31ng/ml vs. 0.77 ng/ml p=0.003). Receiver operator characteristic analysis (ROC) showed at a threshold level of 1.03 ng/ml for ACTB-106 68.6%, sensitivity and 70.4% specificity (AUC: 0.69). ROC analysis showed at a threshold level of 1.70 ng/ml for ACTB-384 57.1%, sensitivity and 81.5% specificity (AUC: 0.73). DNA integrity was increased in RCC (1.07 vs. 0.72 p=0.04). In vascular invasion the DNA integrity was reduced (p=0.003).
CONCLUSION: Cell-free-DNA levels are increased in RCC. The DNA integrity indicates mostly necrotic origin in RCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20683013

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  20 in total

1.  Quantitation of plasma circulating DNA using quantitative PCR for the detection of hepatocellular carcinoma.

Authors:  Zhaohui Huang; Dong Hua; Yu Hu; Zhihong Cheng; Xike Zhou; Qigen Xie; Qiongyao Wang; Feng Wang; Xiang Du; Yanjun Zeng
Journal:  Pathol Oncol Res       Date:  2011-07-21       Impact factor: 3.201

2.  [Circulating cell-free serum DNA: significance as a new biomarker for urological malignancies].

Authors:  J Ellinger; A von Rücker; P J Bastian; S C Müller
Journal:  Urologe A       Date:  2010-09       Impact factor: 0.639

Review 3.  Analysis of circulating tumor DNA in breast cancer as a diagnostic and prognostic biomarker.

Authors:  Mersedeh Rohanizadegan
Journal:  Cancer Genet       Date:  2018-02-24

Review 4.  The Role of Circulating Tumor DNA in Renal Cell Carcinoma.

Authors:  Paulo G Bergerot; Andrew W Hahn; Cristiane Decat Bergerot; Jeremy Jones; Sumanta Kumar Pal
Journal:  Curr Treat Options Oncol       Date:  2018-02-20

5.  Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study.

Authors:  Mark W Ball; Michael A Gorin; Gunes Guner; Phillip M Pierorazio; George Netto; Channing J Paller; Hans J Hammers; Luis A Diaz; Mohamad E Allaf
Journal:  Clin Genitourin Cancer       Date:  2016-03-24       Impact factor: 2.872

6.  Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer.

Authors:  T B Hao; W Shi; X J Shen; J Qi; X H Wu; Y Wu; Y Y Tang; S Q Ju
Journal:  Br J Cancer       Date:  2014-08-26       Impact factor: 7.640

7.  The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis.

Authors:  Shiva Basnet; Zhen-Yu Zhang; Wen-Qiang Liao; Shu-Heng Li; Ping-Shu Li; Hai-Yan Ge
Journal:  J Cancer       Date:  2016-06-04       Impact factor: 4.207

8.  Concentration and Methylation of Cell-Free DNA from Blood Plasma as Diagnostic Markers of Renal Cancer.

Authors:  Inessa Skrypkina; Liudmyla Tsyba; Kateryna Onyshchenko; Dmytro Morderer; Olena Kashparova; Oleksii Nikolaienko; Grigory Panasenko; Sergii Vozianov; Alina Romanenko; Alla Rynditch
Journal:  Dis Markers       Date:  2016-09-20       Impact factor: 3.434

9.  Multiparametric analysis of cell-free DNA in melanoma patients.

Authors:  Francesca Salvianti; Pamela Pinzani; Paolo Verderio; Chiara Maura Ciniselli; Daniela Massi; Vincenzo De Giorgi; Marta Grazzini; Mario Pazzagli; Claudio Orlando
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

Review 10.  Harnessing cell-free DNA: plasma circulating tumour DNA for liquid biopsy in genitourinary cancers.

Authors:  Manuel Caitano Maia; Meghan Salgia; Sumanta K Pal
Journal:  Nat Rev Urol       Date:  2020-03-17       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.